Allogeneic hematopoietic stem cell transplantation in non‐Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better

Allogeneic hematopoietic stem cell transplantation in non‐Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better

Abstract Due to relatively high nonrelapse mortality (NRM), allogeneic hematopoietic stem cell transplantation (allo‐HSCT) in non‐Hodgkin's lymphoma (NHL) remains the ultimate line of treatment but the only curable approach in a setting of relapse/refractory disease. Here, we conducted a retros...

Full description

Bibliographic Details
Main Authors: Ekaterina Rebmann, Mitja Nabergoj, Bastien Grandjean, Paraskevi Stakia, Alix Stern, Michael Medinger, Stavroula Masouridi‐Levrat, Carole Dantin, Urs Schanz, Helen Baldomero, Jakob Passweg, Gayathri Nair, Alicia Rovo, Yves Chalandon
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:eJHaem
Subjects:
GVHD
lymphomas
stem cell transplantation
Online Access:https://doi.org/10.1002/jha2.614

Internet

https://doi.org/10.1002/jha2.614

Similar Items